These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35089489)

  • 1. Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis.
    Dhochak N; Jat KR; Soni KD; Singh Y; Aggarwal R; Lodha R; Trikha A; Kabra SK
    Indian J Pediatr; 2022 Apr; 89(4):404-406. PubMed ID: 35089489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.
    Bain R; Cosgriff R; Zampoli M; Elbert A; Burgel PR; Carr SB; Castaños C; Colombo C; Corvol H; Faro A; Goss CH; Gutierrez H; Jung A; Kashirskaya N; Marshall BC; Melo J; Mondejar-Lopez P; de Monestrol I; Naehrlich L; Padoan R; Pastor-Vivero MD; Rizvi S; Salvatore M; Filho LVRFDS; Brownlee KG; Haq IJ; Brodlie M
    J Cyst Fibros; 2021 Jan; 20(1):25-30. PubMed ID: 33309057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection in a pediatric patient with cystic fibrosis.
    Páez-Velásquez JS; Romero-Uribe IE; Castilla-Peón MF; Lezana-Fernández JL; Chávez-López A
    Bol Med Hosp Infant Mex; 2021; 78(1):29-33. PubMed ID: 33661877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis.
    Hergenroeder GE; Faino AV; Cogen JD; Genatossio A; McNamara S; Pascual M; Hernandez RE
    Pediatr Pulmonol; 2023 Sep; 58(9):2478-2486. PubMed ID: 37314149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis.
    Marques LS; Boschiero MN; Sansone NMS; Brienze LR; Marson FAL
    Healthcare (Basel); 2023 Jul; 11(13):. PubMed ID: 37444770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Correspondence.
    Mandal M; Sarkar S; Esquinas AM
    Indian J Pediatr; 2022 Aug; 89(8):841. PubMed ID: 35403937
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic.
    Patel S; Thompson MD; Slaven JE; Sanders DB; Ren CL
    Pediatr Pulmonol; 2021 May; 56(5):1271-1273. PubMed ID: 33434352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis.
    Jaudszus A; Pavlova M; Rasche M; Baier M; Moeser A; Lorenz M
    BMC Pulm Med; 2022 Mar; 22(1):101. PubMed ID: 35331203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.
    Mathew HR; Choi MY; Parkins MD; Fritzler MJ
    BMC Pulm Med; 2021 May; 21(1):173. PubMed ID: 34016096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Authors' Reply.
    Dhochak N; Lodha R
    Indian J Pediatr; 2022 Aug; 89(8):842. PubMed ID: 35499799
    [No Abstract]   [Full Text] [Related]  

  • 13. Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.
    Arvind B; Medigeshi GR; Kapil A; Xess I; Singh U; Lodha R; Kabra SK
    Indian J Med Res; 2020 Jan; 151(1):65-70. PubMed ID: 32134016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
    Mondejar-Lopez P; Quintana-Gallego E; Giron-Moreno RM; Cortell-Aznar I; Ruiz de Valbuena-Maiz M; Diab-Caceres L; Prados-Sanchez C; Alvarez-Fernandez A; Garcia-Marcos PW; Peñalver-Mellado C; Pastor-Vivero MD; Olveira C; Lopez-Neyra A; Castillo-Corullon S; Palma-Milla S; Perez-Ruiz E; Sole-Jover A; Barrio MI; Sanchez-Solis M; Asensio de la Cruz Ó;
    Respir Med; 2020; 170():106062. PubMed ID: 32843180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
    Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tješić-Drinković D; Yiallouros P; Bilkova A; Olesen HV; Burgel PR; Parulava T; Diamantea F; Párniczky A; McKone EF; Mei-Zahav M; Salvatore M; Colombo C; Aleksejeva E; Malakauskas K; Schlesser M; Fustik S; Turcu O; Zomer-van Ommen D; Wathne AS; Woźniacki Ł; Pereira L; Pop L; Kashirskaya N; Rodić M; Kayserova H; Krivecs U; Mondejar-Lopez P; de Monestrol I; Dogru D; Makukh H; Cosgriff R; van Koningsbruggen-Rietschel S; Jung A;
    J Cyst Fibros; 2021 Jul; 20(4):566-577. PubMed ID: 34016559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
    Colombo C; Cipolli M; Daccò V; Medino P; Alghisi F; Ambroni M; Badolato R; Battistini F; Bignamini E; Casciaro R; Ciciriello F; Collura M; Comello I; Francalanci M; Ficili F; Folino A; Leonardi S; Leonetti G; Lucanto MC; Lucca F; Maschio M; Mencarini V; Messore B; Pisi G; Pizzamiglio G; Poli P; Raia V; Riberi L; Ros M; Rotolo N; Sepe A; Taccetti G; Vitullo P; Alicandro G
    Infection; 2022 Jun; 50(3):671-679. PubMed ID: 34874541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study.
    Hadi YB; Lakhani DA; Naqvi SF; Fatima NU; Sarwari AR
    Respir Med; 2021 Nov; 188():106606. PubMed ID: 34520894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
    McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel PR; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G; Elbert A; Faro A; Goss CH; Gulmans V; Gutierrez H; de Monestrol I; Jung A; Justus LN; Kashirskaya N; Marshall BC; McKone E; Middleton PG; Mondejar-Lopez P; Pastor-Vivero MD; Padoan R; Rizvi S; Ruseckaite R; Salvatore M; Stephenson AL; Filho LVRDS; Melo J; Zampoli M; Carr SB;
    J Cyst Fibros; 2020 Nov; 19(6):868-871. PubMed ID: 33183965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres.
    Moeller A; Thanikkel L; Duijts L; Gaillard EA; Garcia-Marcos L; Kantar A; Tabin N; Turner S; Zacharasiewicz A; Pijnenburg MWH
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
    Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
    Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.